Optimisation of the lion (Panthera leo) specific interferon gamma assay for detection of tuberculosis in lions in South Africa by Khumalo, Nozipho Lindiwe
© University of South Africa 
 
Optimisation of the lion (Panthera leo) specific 
interferon gamma assay for detection of 
tuberculosis in lions in South Africa 
 
NOZIPHO LINDIWE KHUMALO 
 
Submitted in accordance with the requirements for the degree of 
MASTER OF SCIENCE 
IN AGRICULTURE 
at the 
UNIVERSITY OF SOUTH AFRICA 
 
Supervisor  : Mr J Oosthuizen 
    Co- Supervisor : Dr J Crafford 
 
 
 
 
February 2017 
Chapter 1 
© University of South Africa ii 
 
Abstract  
Optimisation of the lion (Panthera leo) specific 
interferon gamma assay for detection of 
tuberculosis in lions in South Africa 
Mycobacterium bovis is the causative agent of bovine tuberculosis (BTB) 
which has a diverse host range. The maintenance host of BTB in South 
Africa is the African buffalo (Syncerus caffer). It is believed that lions get 
infected by feeding on infected buffalo or through wounds. The spread of 
the disease amongst lions has raised concern regarding the future of the 
animals and the impact on tourism in the country. Diagnoses of 
tuberculosis in free ranging wildlife is often dependent on post-mortem 
samples due to logistical challenges, the use of the lion specific interferon 
gamma release assay as an antemortem test offers a simpler 
methodology to testing live animals. The aim was to optimise an already 
developed assay by Maas et al.,2012 and to harmonise it with the 
Rhinoceros specific interferon gamma assay developed by Morar-Leather 
et al 2007. Optimisation of the interferon gamma specific ELISA included: 
determination of optimal concentrations for the capture and detection 
monoclonal antibodies; optimal concentrations for the conjugate and 
evaluation of alternative blocking agents. Different mitogens and 
incubation times were evaluated for the stimulation of whole blood as 
positive control in the assay. The optimum concentration for coating the 
plates with the capture monoclonal antibody was 2 g/ml. An optimum 
dilution of 1:5000 was selected for both the biotinylated detection 
monoclonal antibody and the streptavidin horseradish peroxidase 
conjugate. The assay was optimised using recombinant lion interferon 
gamma and the lower detection limit was calculated to be 109 pg/ml. 
Phosphate buffered saline with 1% bovine serum albumin was found to be 
Chapter 1 
© University of South Africa iii 
 
a suitable blocking agent. Native interferon gamma was detected in whole 
blood samples from 5 lions and a 24 hour incubation time with PMA and 
ionomycin was selected as the optimal mitogen positive control. This 
assay system demonstrated good potential as an ante mortem test for the 
diagnosis of tuberculosis in lions.  
 In conclusion, the assay can detect IFN- from supernatants harvested 
from whole blood cultures stimulated with specific antigens and mitogens 
 Key words: Mycobacterium bovis, Interferon gamma; Bovine 
tuberculosis; ELISA; Lion; recombinant lion; Optimisation 
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1 Chapter 1 
Introduction 
Mycobacterium bovis is the causative agent of bovine tuberculosis (BTB). The 
maintenance host of BTB in South Africa is the African buffalo (Syncerus caffer). During 
August 1990, BTB was reported in a significant proportion of the African buffalo 
population in the Kruger National Park (Bengis, et al., 1996). Cases of BTB in lions have 
been described in captive (Eulenberger et al., 1992; Morris et al., 1996) and free-
ranging lion populations (Keet et al., 1996; Cleveland et al., 2005; Trinkel et al., 2011) 
and the prevalence of the disease could be as high as 79% (Maas et al., 2012). BTB is 
a chronic disease (de Lisle et al., 2002; Michel et al., 2006), and affects mostly the 
lungs and other organs (Keet et al., 1996, 2000; Kirkberger et al., 2006) and can 
eventually lead to fatalities (Keet et al., 2010). Transmission of M. bovis in lions has not 
been proven. However, it has been proposed that prolonged eating of meat from M. 
bovis infected cattle and African buffaloes may be the mode of transmission in lions 
(Eulenberger, et al., 1992; Jones, 1953). Currently, the only validated test for the 
diagnosis of BTB in live animals is the Single intradermal comparative cervical 
Tuberculin test for cattle and it has been applied in lions (Keet et al., 2010). The 
disadvantage of this test is that it requires recapture of animals after 72hrs which is 
labour intensive, stressful for the animal and impractical to use in free-ranging 
populations. 
To know the BTB status of lions is important for disease control purposes, especially in 
case of translocations between zoo’s or wildlife parks and for international trade. 
Other tests like the interferon-gamma (IFN-) release assay (IGRA) are currently being 
investigated to replace the skin test. This assay is based on the detection of IFN- in 
whole-blood culture which is released in response to stimulation with BTB specific 
antigens (Rothel et al., 1992; Wood et al., 1990a). Advantages of this assay include a 
single capture of the animals, an increased sensitivity, early detection of infection, a 
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more standardised procedure and more objective interpretation (Aagaard et al., 2006; 
de la Rua-Domenech et al., 2006; Schiller et al., 2010).   
In this study optimisation of the lion specific IGRA was the main objective, adapting the 
protocol by Maas et al., (2012) using opportunistic available lion samples in South 
Africa. 
1.1 Problem statement 
Tuberculosis (TB) is an infectious lethal disease causing a high number of deaths in 
humans and animals. Lions are cooperative group hunters compared to other cats. 
They prey on African buffalo and their method of hunting ultimately requires the 
suffocation of the prey animal through the occlusion of the respiratory tract. If an 
advanced case of an M. bovis infected animal falls prey, it can be assumed that the lion 
doing the suffocating may inhale large numbers of infectious bacilli. After the prey has 
died, lions may also ingest numbers of infectious bacilli while eating tuberculous lesions.  
When feeding on carcasses, lions have their heads in close proximity to one another 
and heavy breathing and growling is a constant feature of these sessions. It is also 
during these sessions that lions may infect other lions in the pride. From infected 
individuals transmission can occur through horizontal transmission, indicating the lion as 
a possible maintenance host (Eulenberger, et al., 1992). According to the IUCN list of 
threatened species, the lion population trend is decreasing and it was listed as 
vulnerable during 1996, 2002, 2004, and 2008. On news for National Geographic, 
September 30, 2005, interview done by Nicholas Bakalar with Dewald Keet, chief 
veterinarian at Kruger National Park, said that bovine tuberculosis is an ever-increasing 
threat to Kruger lions but because TB is a chronic disease, people may have the 
mistaken impression that it has stabilized. Regardless of the efforts done to control 
BTB, the disease persists, with serious implications for human health and the economy 
in the context of global trade. The IGRA is currently the best method to be used to 
detect infected animals in the early stages of the disease.  
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1.2 Study aim 
The aim of this study was to optimize the lion specific interferon-gamma release assay 
for lions in South Africa.  
1.3 Study objectives 
 Optimisation of the IFN- ELISA 
o Optimization of the IFN- monoclonal capture antibody 
o Optimization of the IFN- monoclonal detection antibody and conjugate  
o Optimization of the blocking buffer  
 Evaluation of different mitogens and incubation times 
1.4 Limitations of the study 
The most challenging aspects of the current study were the difficulties in obtaining fresh 
samples from captive lions, semi-captive and free-ranging lions, therefore, the sample 
size used in this study was insufficient. Ideally information for a capture had to be 
conveyed a week before in order to prepare for the trip, unfortunately, information would 
only be received late and thus missing an opportunity of obtaining fresh samples for the 
study. This also played a huge role in budgeting for the captures planned.  
1.5 Conclusion 
Major improvements in diagnostics, prevention and control of BTB in wildlife have been 
made due to the increased awareness of the disease and its potential environmental 
and socio-economic implications. Though BTB eradication in wildlife is very unlikely to 
happen sooner and resulting in the threat of re-infection of domestic livestock from 
wildlife as a source will remain. A number of options are available to contain, control 
and eradicate BTB, but many are considered unacceptable on economic, moral and 
environmental grounds. 
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The optimized protocol has provided results that show the assays efficiency. Findings 
provide data that one can obtain results within a shorter period (24 hours) of detecting 
interferon gamma in whole blood, but one could still go up to 48 hours testing for 
detection of interferon gamma The level of detection was found at 109 pg/ml. 
With the findings of the current study, the assay can be used as a potential diagnostic 
tool by parks and zoos for testing during veterinary check-ups, translocations and for 
research purposes. 
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2 Chapter 2 1 
Literature Review 2 
2.1  General Overview of Mycobacteria 3 
2.1.1 Introduction 4 
This chapter gives a general overview of tuberculosis in lions and the different ante 5 
mortem diagnostic tests that are currently available. 6 
Bovine tuberculosis (BTB) is caused by Mycobacterium bovis (M.bovis) which is a 7 
chronic infection in cattle, and still remains an economic problem and has a zoonotic 8 
risk for a number of countries. Because of the economic impact that the disease has on 9 
international trade and risks to human health, initiations have led to global programs to 10 
try and eradicate the disease (Cousins DV., 2001) being implemented all over the world. 11 
The presence of maintenance hosts in wildlife presents a transmission risk at the 12 
wildlife-livestock-human interface and may threaten the conservation of susceptible 13 
wildlife species like lions. 14 
Primarily known as a disease of livestock, bovine tuberculosis has also been reported in 15 
African buffalo, lions, cheetahs, chacma baboons, greater kudu, leopard, hyena, large-16 
spotted genet, warthog, bush pig, and eland (Huchzermeyer et al., 1994; Thoen, 1994; 17 
de Lisle et al., 2001; Michel, 2002; Cleveland et al., 2005). Bovine tuberculosis is 18 
thought to have been imported into South Africa through cattle of the European settlers 19 
towards the end of the eighteenth century (Henning, 1956) and has since spread to the 20 
buffalo population in the Kruger National Park (KNP) (Bengis et al, 1996). The 21 
importance of TB in wildlife has only been recognized recently (de Lisle et al., 2002). 22 
Once animals have been infected they tend to act as reservoirs of infection. Some of 23 
the wild animals that can pose as maintenance host of the disease include the African 24 
buffalo (Syncerus caffer), Kafue lechwe (Kobus leche), and White-taled deer 25 
(Odocoileus virginianus) (de Vos et al., 2001). 26 
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2.1.2  Scientific classification of Mycobacteria 1 
Mycobacterium is a genus of Actinobacteria, belonging to the Mycobacteriaceae family. 2 
The genus includes pathogens that can cause serious diseases in mammals; these 3 
include tuberculosis caused by Mycobacterium tuberculosis and leprosy caused by 4 
Mycobacterium leprae (Ryan KJ, Ray CG., 2004).  5 
2.1.3  Microbiological characteristics 6 
Mycobacteria are aerobic, mesophilic, non-motile, non-spore forming and host-7 
associated bacteria, that are characteristically acid fast (Ryan KJ, Ray CG., 2004). They 8 
can grow up to 1.0 to 10µm long and 0.2 to 0.6µm wide. M. bovis is similar in structure 9 
and metabolism to M. tuberculosis. It is a rod-shaped bacterium that stains red with 10 
acid-fast stains like Ziehl-Nielsen. 11 
Mycobacteria have an outer membrane, (Niederweis M, et al., 2010) and do not 12 
have capsules, and most of them form endospores. Mycobacterium marinum and 13 
feasibly M.bovis have shown to form spores (Ghosh JL, et al., 2009). The distinctive 14 
characteristic of Mycobacterium species is that the cell wall is thicker than in many other 15 
bacteria, which is hydrophobic, waxy, and rich in mycolic acids. 16 
 17 
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Figure 2.1 Mycobacterium bovis (Photo Courtesy of CDC 3 June 2007; microbewiki.kenyon.edu; 1 
downloaded on the internet) 2 
The maintenance host of BTB is South Africa is the African buffalo (Syncerus caffer). 3 
During August 1990, BTB was reported in a significant proportion of the African buffalo 4 
population in the KNP (Bengis et al., 2006). M. bovis infection has been reported in a 5 
wide range of animals that include elephants, non-human primates, rhinoceros, tapir, 6 
marine animals, non-domestic ungulates and carnivores, and domestic animals (Thoen 7 
et al., 1977; Forshaw and Phelps, 1991; Montali et al., 2001; Ghodbane et al., 2013).  8 
The first case of tuberculosis (MTB) in South African captive animals was recorded at 9 
the National Zoological Gardens of South Africa by Robinson in 1953. Though pure 10 
cultures of M. tuberculosis were obtained in two cases of springbok at that time, M bovis 11 
was found in a guinea pig that was inoculated with affected lung tissue and therefore 12 
the identity of the causative pathogen is uncertain. Another case reported in South 13 
Africa of MTB infection in a wild animal was of a chacma baboon from a free-ranging 14 
troop in a rural region of Limpopo Province (Kovalev, 1980). Another case reported in 15 
Chachma baboons was in 1998 in a single troop of free-ranging in the KNP that fed on 16 
infected carcasses scavenged in the wild or from a post-mortem facility. Necropsy 17 
findings presented severe miliary lesions of the lungs and spleen, indicating that the 18 
disease enters the blood stream and then disseminates to distal sites (Keet et al., 19 
2000). The isolations of Mycobacterium tuberculosis found were similar to that found in 20 
African buffalo in the KNP. 21 
Another M. tuberculosis case reported at the IThemba laboratories was from a semi-22 
free-ranging springbok living on the grounds of IThemba Laboratory for Accelerator-23 
Based Science in Cape Town (Gous and Williams, 2009). A study done in Kenya, on a 24 
rehabilitated elephant that was released back to the wild showed histological and gross 25 
pathology of MTB infection after its fifth year in the wild (Obanda et al., 2013).  26 
Michel and co-workers (2006) also reported an M. bovis strain in kudu that was 27 
genetically similar to that found in buffalo. Other cases with genetically unrelated M. 28 
bovis strains were also detected, suggestive of different sources of infection. Keet et al., 29 
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2001) also suggested another possible mode of transmission of M. bovis amongst kudu, 1 
and between cattle and kudu being the secretion of infectious pus from draining fistulae 2 
of parotid lymph nodes. 3 
The majority of tuberculosis in wildlife is caused by M. bovis infection, reflecting its 4 
broad host range. It has been reported in a wide range of animals that include inter alia: 5 
African buffalo (Syncerus caffer), wildebeest (Connochaetes), lions (Panthera leo), 6 
cheetahs (Acinonyx jubatus), leopard (Panthera pardus), chacma baboons (Papio 7 
ursinus), greater kudu (Tragelaphus strepsiceros),  hyena (Hyaenidae), impala 8 
(Aepyceros melampus), large-spotted genet (Genetta tigrina), warthog (Phacochoerus 9 
africanus), bush pig (Potamochoerus larvatus), eland (Taurotragus oryx), spotted hyena 10 
(Crocuta crocuta), lechwe (Kobus leche), common duiker (Sylvicapra gremial), honey 11 
badger (Mellivora capensis) (Keet et al., 1996; de Vos et al., 2001; Cleveland et al., 12 
2005; Michel et al., 2006; Trinkel et al., 2011; OIE, 2012) 13 
A control programme for managing BTB was initiated at the Hluhluwe- imfolozi Park in 14 
1999 because of the increasing BTB prevalence, which aimed at reducing the number 15 
of buffalo herds infected with M. bovis to below 10% as well as the spill-over into key 16 
species and domestic livestock in the surrounding areas (Michel et al., 2006). 17 
2.1.4 An Outline of tuberculosis in lions 18 
The first BTB cases in lions were first reported in 1995; then it was reported in 19 
cheetahs. Leopards were later reported in 1998, since then 50 more cases of lion 20 
infections have been reported.  21 
Tuberculosis has been reported in many felid species in captivity and in the wild, 22 
including leopard (Panthera pardus) (Eulenberger et al.,1992), cheetah (Acinonyx 23 
jubatus) (Keet et al., 1996), ocelot (Leopardus pardalis) (Eulenberger et al., 1992), 24 
common genet (Genetta genetta) (de Lisle et al., 2002), snow leopard (Uncia uncia) 25 
(Eulenberger et al., 1992, Thorel 1994) and Amur leopard (Pathera pardus orientalis) 26 
(Thorel.,1994).  27 
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It is well established that lions are susceptible to M. bovis infection. Tuberculosis is a 1 
chronic disease and can affect multiple organs of the body specifically the lungs (de 2 
Lisle et al., 2002; Keet et al., 2000), and can lead to fatalities (Keet et al., 2010). The 3 
prevalence of BTB in lions requires disease surveillance in events of translocations 4 
between zoo’s or wildlife parks or for research purposes. Lions have been categorized 5 
as spill-over hosts (Keet DF., 2000) in their populations as this depends on a persistent 6 
alternate source of infection (de Lisle et al., 2002). The risk imposed by BTB infections 7 
in lions may be increased by simultaneous infections with Feline immune deficiency 8 
virus (FIV), potentially increasing their susceptibility to BTB (Maas et al, 2012). 9 
According to the IUCN Red List of Threatened Species, lions are listed as vulnerable 10 
and have experienced a 43% population decline over the past 21 years. The KNP 11 
populations and the Serengeti are two of the few remaining strongholds of lions that are 12 
considered to be genetically viable (Bauer et al., 2008). The decline is primarily due to 13 
the killing of lions to protect human life and livestock as well as reduction in wild pray 14 
availability and habitat loss, in addition to this, tuberculosis is also considered a threat to 15 
lion populations (Nowell et al., 2012) 16 
The first reported cases of lions contracting tuberculosis were from animals in captivity 17 
(Eulenberger et al., 1992; Morris et al., 1996). Cases of tuberculosis in primates and 18 
felid species and the management thereof in the Leipzig Zoological Gardens in 19 
Germany were reported between 1951 and 1990 by Eulenberger et al., 1992. The 20 
report included all felid species housed at the zoo including leopard (Panthera pardus), 21 
tiger (Panthera tigris), puma (Puma Concolor), lynx (Lynx lynx) but lions were the most 22 
often diagnosed with tuberculosis (Eulenberger et al., 1992). In 1996 the second report 23 
from another zoo was published and reported on tuberculosis due to M. bovis in lions. In 24 
Knoxville Zoo, the USA, an eight- year- old male lion was euthanized in 1985 due to 25 
continuous deteriorating health (Morris et al., 1996). 26 
In free-ranging African lions the first report of M. bovis was in 1996 in two lionesses in 27 
the KNP, South Africa (Keet et al., 1996). The approximate age of these two lionesses 28 
was about 10 years with one emaciated to a point that it couldn’t even stand. Both of the 29 
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females had similar lung lesions. Since the publishing of this report, many more lions 1 
with tuberculosis have been identified in the KNP (Keet et al., 2000, 2010). More cases 2 
of lions with tuberculosis were reported in KwaZulu Natal in the Munyawana Game 3 
Reserve (Michel et al., 2006, 2009; Trinkel et al., 2011). In Hluhluwe ImFolozi Park 4 
(HIP), post-mortem inspection and culture samples from lions that had died (most likely 5 
from tuberculosis) or that were euthanized due to advanced emaciation were used as 6 
confirmation of infection of M.bovis (Trinkel et al., 2011). 7 
Tuberculosis might not just be a problem in Kruger National Park lions but may also 8 
have an impact in other parks in Africa. M.bovis infection was reported in free ranging 9 
lions in the Serengeti National park in Tanzania (Cleveland et al., 2005). Serum 10 
samples collected over the period 1984-2000 were subjected to M. bovis antibody 11 
ELISA. The results indicated that mycobacterial infection was present in the Serengeti 12 
lions from as early as 1984. Though the results could not classify the species of the 13 
Mycobacterium Tuberculosis Complex involved, isolation of M. bovis from lion prey 14 
species suggested it is a likely candidate (Cleveland et al., 2005).  15 
Currently, the only validated test for use as a diagnostic tool in lions is the tuberculin 16 
skin test (Keet et al., 2010). Although the test has been adapted for use in lions it is very 17 
impractical in wild populations and expensive as it requires two visits to the farm. Other 18 
diagnostic methods have been investigated to replace the skin test which includes the 19 
interferon gamma release assay (IGRA) which compliments the tuberculin tests in both 20 
humans and cattle (Shiller et al., 2010; Gormeley et al., 2006). The IGRA is based on 21 
tuberculin specific stimulation (bov PPD and av PPD) of cell mediated-immunity (CMI) 22 
and measures production of IFN-. Advantages of IGRAs are its increased sensitivity, 23 
detection of infection at an earlier stage of infection, the opportunity repeat testing, 24 
requires only one capture of the animal and more objective test procedures and 25 
interpretation [Chambers M. A., 2009; Rhodes et al., 2008; Rhodes et al., 2011) 26 
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2.1.5 Routes of infection 1 
Inhalation is considered to be the primary route of infection in cattle and in many other 2 
species, with primary lesions occurring in the lungs and associated lymph nodes and/or 3 
in lymphoid tissues of the head (Eulenberger et al., 1992). This appears to be the main 4 
route of infection for big cats in Kruger National Park, presumably associated with 5 
suffocating their prey (Keet et al., 2002). Ingestion is the important route for some 6 
species, particularly carnivores, and the transcutaneous transmission has occurred 7 
occasionally in humans with cuts/ abrasions handling infected carcasses, and biting is 8 
known as the route of infection, for example meles-Eurasian badger.  9 
2.1.6  The spread of bovine tuberculosis to lions  10 
The spread of infection in lions and other wildlife species became evident in 1995 (Keet 11 
et al., 1996). This poses a direct health consequence for the lions but also causes a 12 
threat to the biggest tourist attraction of the park (de Lisle et al., 2002, Kirkberger, Keet 13 
& Wagner 2006). In the KNP buffaloes are one of four preferred prey species of lions 14 
and get preyed on extensively more in dry seasons (Keet, Michel & Meltzer 2000). 15 
Funston 1998 stated that weak animals are an easy target for lions because they are 16 
easy to kill. There seems to be a connection between increasing prevalence of BTB in 17 
buffalo herds and a decrease in overall body condition score (Caron, et al., 2003).  This 18 
mechanism of spread has led to increased exposure of lions to M. bovis. In areas where 19 
the occurrence of BTB in buffaloes is high the infection is also more prevalent in lions. 20 
Therefore, prides in the south of the park are more affected than prides in the north. 21 
Keet et al., 2000 stated that adult lions are more likely to be infected than sub-adults 22 
and cubs. Since the prevalence of BTB amongst buffalo is still increasing, so is the 23 
threat of BTB to lions. It is likely that the majority of the KNP lions may become infected 24 
in the future (Keet et al., 2000). 25 
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2.1.7 Mycobacterium bovis transmission between lions 1 
Although lions have the potential to be spill-over hosts (de Lisle et al., 2002), additional 2 
evidence has shown that lions are likely to be maintenance hosts, managing to maintain 3 
the infection within their prides in different ways. Factors that can play a role in the 4 
propagation of infection amongst lions include social behaviour like sociality, 5 
intraspecies aggression as well as a preference for hunting buffaloes (Keet et al., 2001). 6 
Aerosol droplets have been suggested to also cause horizontal transmission for M. 7 
bovis bacteria (Eulenberger et al., 1992). Fine aerosol suspensions of low viscosity 8 
carrying the organism are very effective for transmission. Food and water can also be 9 
contaminated with the organism. Another form of spread is simultaneous or sequential 10 
feeding after contamination of the carcasses/food sources with infected oral secretions. 11 
Inhalation is considered to be the primary route of infection in cattle and in many other 12 
species, with primary lesions occurring in the lungs and associated lymph nodes and/or 13 
in lymphoid tissues of the head. This appears also to be the main route of infection for 14 
big cats presumably associated with suffocating their prey (Keet et al., 2002). 15 
Aerosol transmission is not the only route of transmission, infection of young animals 16 
suggests that transmission by milk is also a likely route, young animals have shown 17 
signs of severe infection and M. bovis has been isolated from the mammary lymph 18 
nodes of three lionesses (Keet, Michel and Meltzer 2000). This transmission hasn’t 19 
been proven yet, though studies with badgers have shown that in that species, the most 20 
important route of transmission is via aerosol, and this may already begin when cubs 21 
are very young, getting the bacteria from their mother (Clifton-Hadley, et al.,1993). 22 
Fighting amongst male badgers seems to be a notable route of transmission and this 23 
can also apply for male lions (Cheeseman, et al., 1989). 24 
2.2  Pathogenesis  25 
Tuberculosis is known primarily to be an infection of the respiratory tract, where bacteria 26 
uses macrophages as primary host cells for duplication of cells (Pollock, et al., 2006). 27 
The general accepted mode of transmission of M. bovis to cattle is by inhalation of 28 
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tubercle bacilli, in an aerosol droplet (Neill et al.,1994) that lodges within the respiratory 1 
tract, most probably the alveolar surface of the lung (Pritchard, 1988). Aerosol 2 
transmission depends on the size and consistency of the aerosolized droplets. Pollock 3 
and Neill (2002) state that fine aerosol suspensions of small viscosity appear to be most 4 
efficient for delivering mycobacterial content, however only a very small portion of those 5 
droplets contain viable bacilli up to one hour after release. After deposition of bacilli on 6 
the respiratory surface, phagocytosis ensures interaction with innate immune response 7 
and CMI take place, B-lymphocytes get activated and antibody titres amplify in later 8 
stages of the infection (Pollock et al., 2006). Infection with mycobacteria such as M. 9 
bovis results in the development of granulomas, comprised of a core of infected and 10 
killed macrophages surrounded and infiltrated by T-lymphocytes within lungs and lymph 11 
nodes. The role of the granuloma is to control and restrict the spread of infection, but 12 
results in major tissue damage (Widdison et al., 2006). The size of the challenge dose is 13 
positively correlated with severity of the disease (Pollock and Neill 2002). 14 
2.3 Clinical signs  15 
Tuberculosis is a chronic infection; initially clinical signs are not evident which makes 16 
diagnosis difficult (de Lisle et al., 2002). Lions that test positive for the skin test can be 17 
found in good condition. Eulenberger et al., 1992, described BTB infection in zoo lions 18 
as a progression where clinical signs could develop very suddenly after latency. Signs 19 
seen were increased emaciation and a lack of enthusiasm to move, after short 20 
exercises animals showed severe dyspnoea (Eulenberger et al., 1992).  Keet et al., 21 
2000 also mentioned other clinical signs like emaciation, depression, alopecia, and 22 
unilateral ocular lesions. The skin also shows a dull, rough appearance and dermatitis 23 
where lions were bitten. In progressed stages swollen joints and elbow hygromas are 24 
often seen in younger animals (Keet, Michel & Meltzer 2000). Macroscopic and 25 
microscopic lesions are seen throughout the lymphatic system especially the 26 
mesenteric, peripheral and head lymph nodes. Lesions found are usually well 27 
advanced, but do not show signs of caseation or calcification and their appearance are 28 
unlike those of traditional TB lesions of ruminants and primates (Bengis RG and Keet 29 
DF., 2000). 30 
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2.4 Ante mortem test for testing BTB specifically to lions 1 
M. bovis incidences in free-ranging lions have urged the need for new diagnostic 2 
methods for the lion species. The use of single blood-based tests are tempting for use 3 
in wildlife testing, since it only requires a once of handling of animals, which assist in 4 
decreasing stress for the animal and reduces chances of injuries during captures 5 
(Waters et al., 2005) The chronic nature of the disease makes diagnosis of M.bovis in 6 
lions complicated as initially clinical signs may not be seen and infected lions may be 7 
found to be in good condition (de Lisle et al., 2002).  8 
Clinical signs can be observed to tell if an animal might be infected but apart from that 9 
ante mortem tests for the detection of BTB in lions are available and they include the 10 
skin test (SICT: Single Intradermal Cervical Test) (Keet et al., 2010) and serology 11 
(ELISA). The SICT currently used for diagnosis of BTB has a sensitivity of 86.5% and a 12 
specificity of 81% (Keet et al., 2010). It is capable of detecting infection in earlier stages, 13 
but its disadvantage is that animals need to be recaptured after three days (72h), which 14 
makes it expensive to use as it is time and money consuming and it also causes stress 15 
for the animals and difficult to implement as often lions cannot be recaptured. The IGRA 16 
also based on CMI seem to provide good results in cattle and buffaloes, but its 17 
disadvantage is that blood needs to be processed within a stipulated period after 18 
collection and that might not be practicable to do in the field. Although the uses of 19 
serological assays has the advantages of logistics, lower costs, and are easily 20 
applicable, Serology also has its disadvantages like the lack of sensitivity in early stages 21 
of infection. 22 
Due to the chronic nature of the disease, it can persist subclinical for extended periods 23 
(de la Rua-Domenech et al., 2006). Because CMI usually develops mostly within weeks 24 
it can then be measured using the FN- assay and the tuberculin skin test. But when 25 
CMI deteriorates, the FN- response will be reduced, this is called the anergic stage, 26 
which can be induced by stress (Pollock and Neill 2002). Slowly humoral response 27 
develops meaning that the animal starts producing antibodies, which can be measured 28 
using serological tests. Recently new diagnostic assays have been developed for a 29 
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number of wildlife species that seem to have satisfactory sensitivity and specificity best 1 
for routine testing (Lyashchenko et al., 2008). Preliminary studies done with new 2 
serologic assays have the potential to be used as diagnostic tests (Miller et al., 2012).  3 
2.5 Immune responsiveness after M. bovis infection 4 
In tuberculosis, the immune response aims to contain an intra-cellular bacterium that 5 
does not make toxins (de Lisle et al., 2002). According to Pollock et al., 2001 there is a 6 
general agreement that CMI plays a major role in controlling the infection. There are 7 
quite a few ways in which the infection may develop when an animal is exposed to M. 8 
bovis. The diverse immune responses can lead to killing the bacterium, a dormant state 9 
of the bacterium and to development of active tuberculosis (Welsh, et al., 2005). 10 
External factors such as poor nutritional status, pregnancy or stress can lessen 11 
resistance to bovine tuberculosis, but there is little definite information on the impact of 12 
these factors on the progression of the disease (Pollock and Neill 2002). 13 
Infection progression in the host is depended on the balance between different anti-14 
mycobacterial immune responses (Welsh et al., 2005). Referring to unpublished data it 15 
shows that the initial challenge dose of M. bovis also influences the result (Pollock and 16 
Neill): higher challenge doses are linked with cell-mediated immune response that 17 
develops within weeks with rapid generation of circulating antibodies. Lower challenge 18 
doses produce a steadier development of the CMI and little or no antibody response 19 
(Pollock and Neill 2002). 20 
The most important macrophage that hosts the bacteria is the effector cell for control of 21 
mycobacterial infections; however, the T-lymphocyte is the main inducer of the 22 
protective acquired immune response (Buddle et al., 2002). T-cells can be divided into 23 
T-helper cells expressing the CD4+ marker and cytotoxic T-cells expressing the CD8+ 24 
marker. The CD4+ T-helper cells recognise antigen presented on class II major 25 
histocompatibility complex (MHC) molecules, while CD8+ cytotoxic T-cells only 26 
recognise antigen presented on class I MHC molecules (Gajewski, et al., 1989, Howard, 27 
Zwilling 1999). T-helper cell can be differentiated into two types, T-helper 1 (Th1) or T-28 
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helper 2 (Th2) cells, depending on the type of cytokines and signals from the antigen 1 
presenting cells that activate them. Th1 cells secrete INF- and another type 1 cytokine 2 
such tumour necrosis factor-α (TNF- α) (Finkelman et al., 1990, Hernandez-Pando et 3 
al., 1996). 4 
Cell-mediated immunity develops after an animal is infected.  CD4+ Th1 cells are first 5 
mediated and then become activated under the influence of interleukin-12 (IL-12). The 6 
Th1 cells are considered essential to activate macrophages and are able to contain the 7 
mycobacterial bacilli (Hernandez-Pando et al., 1996, Buddle et al., 2002). Th2 cells 8 
secrete IL-4, a type 2 cytokine that assists with B-cell activation and antibody production 9 
and is associated with the chronic and progressive phase of the infection (Finkelman et 10 
al., 1990, Hernandez-Pando et al., 1996).  11 
2.6  Pathology 12 
Lions tend to show completely different macroscopic lesions from the ones described in 13 
ungulates and non-human primates and are difficult to identify, except for the pulmonary 14 
lesions. No abscesses or calcification are present (de Lisle et al., 2002). In more 15 
advanced cases pulmonary lesions are usually seen and only macroscopic lesions can 16 
be pathognomic (Keet, Michel & Meltzer 2000). In cases where the lung changes are 17 
most noticeable, an aerosol infection is most likely to have been the transmission route 18 
(Eulenberger et al., 1992). Keet described the tuberculosis lesions in the lungs which 19 
showed signs of bronchiectasis and numerous fibrous but fairly thin-walled cavities in 20 
the lungs with small quantities of opaque, greyish-white mucoid exudates. These do not 21 
essentially need to contain many acid-fast bacilli (Keet et al., 1997). Cases where 22 
histopathology was performed, showed granulomatous pneumonia, but no necrosis 23 
occurred in the inflammatory reaction (Keet, Michel & Meltzer 2000). The multinucleated 24 
massive cells that are important in the granulomatous reactions of buffaloes, kudus and 25 
baboons, were lacking from the lesions in lions (Keet et al., 1997). 26 
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2.7 Current diagnostic methods used for the detection of bovine tuberculosis 1 
in wildlife according to the OIE 2 
The diagnosis of tuberculosis in wildlife often relies on post-mortem because of the 3 
logistical challenges and lack of field-friendly techniques for live animal testing. The 4 
Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the Office 5 
International des Epizooties (OIE) lists several diagnostic tests that can be used to 6 
detect M. bovis infection in cattle. Increasing perception has raised awareness that no 7 
single method is adequate for detecting BTB infected animals (Salfinger and Pfyffer 8 
1994). As a result, a multidisciplinary approach is essential, based on the currently 9 
available methods. Below, are some of a various antemortem tests employed as 10 
diagnostic methods currently used for diagnosing BTB. 11 
Identification of the agent: 12 
 Microscopic examination of smears stained with Ziehl Neelsen stain method 13 
provides presumptive evidence 14 
 Isolation of mycobacteria on selective culture media 15 
 Nucleic acid recognition methods by identification and biochemical tests or Gen-16 
Probe TB complex DNA probe or polymerase chain reaction (PCR)  17 
- Delayed Hypersensitivity test 18 
o Single Intradermal test (SIT) 19 
o Single intradermal comparative cervical tuberculin test (SICCT) 20 
- Blood-based Laboratory tests 21 
o Lymphocyte proliferation assay 22 
 This test is done in-vitro and is based on the comparison of the 23 
reactivity of blood lymphocytes to avian and bovine purified protein 24 
derivative, however, the test has scientific value, but it is time-25 
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consuming, and laboratory procedures are complicated and 1 
expensive so it is not used for routine purposes. 2 
o Gamma-interferon release assay 3 
o Enzyme-linked immunosorbent assay (ELISA) 4 
2.7.1 The best Test to use 5 
When the aim is to eradicate infection, tests based on cellular immunity are the most 6 
important to use, as the infection can be detected in the early stages. If controlling 7 
infection is the aim, it is important to identify shedders of the bacteria earlier, e.g. the 8 
use of serology is important. The major disadvantage of using the ELISA test for 9 
detection of antibody to M. bovis infection in cattle is that there is usually the late and 10 
irregular development of humoral immune response in cattle during the course of the 11 
disease. In wildlife absence of routine testing and test and slaughter policy, infected 12 
animals have the chance to reach the Th2 stage different to cattle that is removed 13 
before the stage (Pollock et al., 2001). 14 
Single blood–based tests (IGRA and ELISA) are tempting to use for wildlife, since they 15 
are cheap in terms of logistics, due to the stability of antibodies during transport, storage 16 
and handling, which reduces costs and increases the ease of application. This is less 17 
stressful for the animals and reduces chances of injuries (Waters et al., 2005). Assays 18 
that are done in vitro, cell-based assays like the IGRA seem to provide good results for 19 
cattle and buffalo, their disadvantage is that blood needs to be processed within a 20 
certain period of time in conditions that might not be possible in the field. Ab detecting 21 
doesn’t have this disadvantage, but it has advantages in terms of logistics, cost, and 22 
they are easy to apply. Up to this day, no M. bovis specific antibody detecting assay has 23 
shown sufficient sensitivity or specificity suitable for routine diagnostic use and more 24 
information is needed about antigens recognized by antibodies produced during 25 
infection (Cousins D.V and Florisson 2005, Waters et al., 2005). According to Pollock et 26 
al., 2001, regular testing is not possible in wildlife, most animals are most likely to reach 27 
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the advance state with the humoral immune response, and serology might be practical 1 
in wildlife, where the test would not be valuable in regularly tested animals. 2 
2.7.2 Culture (Golden standard) 3 
Culture is regarded as a golden standard for diagnosing BTB, but the process is long, 4 
and obtaining samples is difficult on living animals. Veterinary and medical laboratories 5 
use different culture systems to isolate mycobacteria. The reason for this is that strains 6 
of M. bovis grow poorly or they may even not grow at all on the glycerol-based media 7 
traditionally used to culture M. tuberculosis. Due to the lack of poor growth, sodium 8 
pyruvate media is used instead of glycerol for isolation of M. bovis (WHO, 1996). In 9 
addition, it has been acknowledged that mycobacteria grow faster in liquid medium 10 
(Salfinger and Pfyffer 1994). When comparing the genus Mycobacterium to other 11 
microorganisms, it has very high nutritional needs compared to other microorganisms. 12 
To detect the mycobacteria from contaminated samples like sputum, milk or tissue 13 
lesions, decontamination methods should be used to eliminate competitive 14 
microorganisms. Decontamination of samples involves the addition of 1 to 5% sodium 15 
hydroxide (NaOH), which is followed by additional treatment with oxalic acid (C2H2O4), 16 
or quaternary ammonium compounds (Young J.S et al., 2005). Another method of 17 
decontamination is by using 0.75% cetylpyridinium chloride (Corner L.A., 1994; OIE, 18 
2008). Although decontamination is important, the toxic effects caused by it may affect 19 
mycobacterial viability, therefore interfering with culturing the organism (Holanda, et al., 20 
2002). The growth rate of M. bovis may take up to 6-8 weeks (Wards, et al., 1995). If M. 21 
bovis is grown on a suitable pyruvate-based solid medium, the colonies come out 22 
smooth and off-white. Although culture is regarded as a golden standard for confirming 23 
BTB it lacks specificity and sensitivity (Coetzer, Tustin 2004). 24 
2.8 Assays based on cellular immunity  25 
2.8.1 Intradermal tuberculin test 26 
The intradermal tuberculin test has been used for more than 100 years, and it is still the 27 
most used test to diagnose BTB in cattle (Monaghan et al., 1994) it is also called the 28 
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single intradermal cervical tuberculin test (SITT). The test is done in vivo and it is based 1 
on an intra-dermal injection of a purified protein derivative (PPD) of M. bovis origin (bov 2 
PPD). When done in conjunction with the injection of PPD of M. avium origin (av PPD), 3 
the test is identified as the comparative cervical intradermal tuberculin test (CITT). The 4 
test requires a second visit seventy-two hours from the day of injection (3 days), the 5 
skin thickness is measured and the skin swelling is used as a measure of 6 
hypersensitivity to the antigens used (Brasil, 2006). Cattle infected with M. avium, M. 7 
tuberculosis, M. avium paratuberculosis, Nocardia farcinica, or other mycobacteria 8 
could be reactive to bov PPD, leading to false-positive results. Regardless of the broad 9 
usage of this test, its sensitivity ranges from 68 to 95%. Specificity for the CITT ranges 10 
from 96 to 99%. The major disadvantage of this test is that it requires two visits to see 11 
the same animals within 3 days (Monaghan et al., 1994), making it expensive and time-12 
consuming (Lilenbaum et al., 2001). Using the skin test as an exclusive diagnostic tool 13 
does not detect all infected animals the bacteria can live in anergic animals that serve 14 
as reservoirs, which could compromise the removal of the source of infection (Liebana 15 
et al., 2008). 16 
2.8.2 Interferon-gamma release assays 17 
IFN- is a cytokine produced by lymphocytes, and in small amounts produced by natural 18 
killer cells, in response to intracellular antigen or mitogen stimulation (Farrar, Schreiber 19 
1993). Pollock et al., 2001 states that it stimulates the macrophages by up-regulation of 20 
the MHC-expression, thereby augmenting antigen presentation. It is known to have a 21 
major role in anti-mycobacterial immunity, and is produced by both CD4+ and CD8+ T-22 
cells 23 
Immune response of mycobacterial infections is mainly cellular. Wood and Rothel 1994 24 
recommended that primary diagnostic techniques should be based preferably on the 25 
measurement of T lymphocyte responses. Due to the limitations of the intradermal 26 
tuberculin tests a rapid (24 hour) in-vitro cellular assay based on the detection of IFN- 27 
which is released in response to specific antigens in whole-blood culture for the 28 
detection of bovine tuberculosis was developed by (Wood et al., 1990a). 29 
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The production of monoclonal antibodies for specific bovine IFN- facilitated the 1 
development of sandwich enzyme immunoassays (ELISA) for bovine IFN- (Rothel et 2 
al., 1992, Wood et al., 1990a). Since the assay is able to detect cases in very early 3 
stages of infection, it helps in identifying some tuberculosis skin test-negative cattle 4 
(Gormley et al., 2006; Neill et al., 1994). Cagiola et al., 2004 did a study in which they 5 
reported a higher specificity with ranges from 97.3% to 98.6% than the skin test, 6 
depending on the tuberculin used. Another study in Brazil where the comparison of the 7 
IGRA and the tuberculin test was done under field conditions, for the diagnosis of 8 
bovine tuberculosis, reported a higher sensitivity of the IGRA than the skin test, 9 
sensitivities ranged from 100 and 88.3%, respectively (Lilenbaum et al., 1999b). The 10 
IGRAs primary advantage is that animals are handled once. In addition to that, the test 11 
can be repeated as often as wanted as the status of the animals remains unchanged 12 
since stimulation of lymphocytes is carried out ex vivo and the animal is not injected 13 
with PPD (Whipple et al., 1995). The interpretation of results of the assay makes it ideal 14 
to use since results are based on numerical values, instead of hypersensitivity reactions 15 
measured in the skin. The use of the IGRA has a disadvantage in terms of processing 16 
samples. It requires processing samples in a well-equipped laboratory, making the cost 17 
of conducting tests higher than the skin test (Lilenbaum et al., 1999).  18 
Although the ELISA shows low sensitivity, it has the potential to be used as a diagnostic 19 
tool for BTB diagnosis by complementing CMI and determining anergic animals. This is 20 
ideal to use in cattle as they are tested regularly, whereas in wildlife where testing is not 21 
done as frequently more animals reach the Th2 stage of infection. Serology then plays a 22 
role of testing shedders. Animals that have a defined infection status should be tested 23 
more and serology results should be correlated to CMI results. 24 
2.8.2.1 The principle of the IGRA 25 
Antibodies specific to IFN- are used to coat plates. Supernatants of lymphocyte 26 
cultures stimulated with PPD’s or other relevant antigens are added. IFN- in the 27 
supernatants will bind to the monoclonal antibodies (capture antibodies), the samples 28 
are discarded, monoclonal or polyclonal antibodies specific for IFN- are added 29 
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(detecting antibodies). Lastly, secondary antibodies with specificity for the detection 1 
antibodies are added; the substrate is added and a colour change is measured 2 
spectrophotometrically. Colour development represents the presence of IFN- or an 3 
indication that the animals tested have been sensitised to the relevant antigen.  4 
  5 
 6 
Figure 2.2  Principle of the capture ELISA; vlab.amrita.edu, (2011). Retrieved 1 July 2016, from 7 
vlab.amrita.edu 8 
2.9 Assays based on antibody detection 9 
Serological assays are based on antibody detection. Although they cannot be 10 
considered as first choice diagnostic methods for diagnoses of tuberculosis, a number 11 
of researchers have described strategic approaches for their use (de la Rua Domenech 12 
et al., 2006; Lilenbaum, Fonseca 2006, and Silvia 2001).  13 
A report stated that researchers recommended the use of serological assays, were 14 
mostly based on the presence of anergic animals and in advance stages of the disease 15 
increased antibody titres are observed (Pollock & Neill 2002; Welsh et al., 16 
2005).Eighteen herds of cattle involved in a tuberculosis control programme were tested 17 
by Lilenbaum & Fonseca 2006 using the ELISA antibody detection assay in order to 18 
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identify infected cows, which they later confirmed infection of M. bovis from lung lesions. 1 
In order to improve the control of tuberculosis by identifying anergic cows, antibody 2 
detection was used as a complementary diagnostic test.  3 
The disadvantage of serology is that it is less effective in identifying infected cattle in the 4 
early stages of infection as antibody levels are low, (Wood et al., 1994). There are 5 
several technical advantages for using antibody detection methods e.g. ELISA, which 6 
assists in the diagnosis of BTB: animals are handled once and only one visit to the farm 7 
is required, blood sampling can be repeated as often as required without altering the 8 
immune status of the animal, results interpretation is based on numerical values and it 9 
makes it more ideal than the measurement of swelling of the skin (Lilenbaum et al., 10 
2001).  11 
The ELISA measures the binding of specific antibodies to an antigen (Lilenbaum et al., 12 
1999). There are specific antigens used to diagnose cattle infected by M. bovis, and 13 
they are called purified antigens from M. bovis (Fifis et al., 1994, Lilenbaum, Fonseca, 14 
2006; Lilenbaum et al., 1999; Silvia, 2001; Waters et al., 2006). Wiker and Harboe, 15 
1992 reported that antibodies directed against these antigens may also be present in 16 
non-infected individuals leading to false positives.  17 
Lilenbaum et al., 2001 conducted a study in Brazil and used an ELISA with Ag85 as 18 
antigen and obtained a sensitivity of 91.3% and specificity of 94.8%. Although in other 19 
studies, reports showed high specificity of antibody detection. The sensitivity of ELISA 20 
employing this antigen was lower (18%) (Fifis et al., 1994; Harboe et al., 1998; Juarez 21 
et al., 2001; Pollock et al., 1994)  22 
The MPB70 protein represents approximately 10% of the PPD, and has been identified 23 
as a B-cell target in cattle with tuberculosis,  Wiker and Harboe., 1992; Lightbody et al., 24 
2000) (Billman-Jacobe et al., 1990; Harboe et al., 1998; Radford et al., 1990). MPB70 25 
and MPB83 are secreted mycobacterial proteins which are regarded as highly 26 
homologous with limited species distribution (Chambers et al., 2004). In M.bovis cases 27 
the two proteins are expressed highly, but less in M. tuberculosis, both in vitro and in 28 
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vivo (Wiker and Harboe., 1992). Diagnostic potential of these proteins was established 1 
by Wiker et al., 1998, they reported that several monoclonal antibodies identify shared 2 
epitopes on these molecules and that the linear epitopes of MPB70 were the major 3 
antibody targets, both upon immunization with protein preparations and during infection 4 
with M. bovis. When comparing MPB83 with MPB70, there were slight differences. 5 
Current studies demonstrated the effectiveness of the MPB83 to diagnose tuberculosis 6 
earlier than MPB70 in experimentally infected animals. MPB83-ELISA detected specific 7 
antibodies four weeks after being infected, whereas MPB70-ELISAs detect specific 8 
antibodies 18-22 months after experimental infection (Wiker 2009). 9 
The use of MPB70 as an antigen on antibody ELISAs, yielded results with good 10 
specificity ranging from 88 to 96%, whereas the sensitivity was quite inconsistent, 11 
ranging from 18 to 73% (Wiker., 2009). The drive to test specific epitopes of the protein 12 
MPB70 to increase the test specificity was due to cross-reactivity with Nocardia 13 
(Lightbody et al., 2000; Radford et al., 1990). In addition, rM70-83-E6, a combination of 14 
MPB70, MPB83 and ESAT-6 antigens, specifically reacts with bovine tuberculosis-15 
positive sera, also improving ELISA sensitivity and specificity (Liu et al., 2007). 16 
Other studies done on antibody detecting ELISA‘s used bov PPD as an antigen, and 17 
produced good sensitivity (90%) and specificity of (89.9%) (Ritacco et al., 1987)  In 18 
addition, in Mexico a study done which was using the same test, reported on sensitivity 19 
of 76.5% (Casillas et al., 1995), while Lilenbaum et al., 1999a reported 86.7% sensitivity 20 
and 90.6% specificity in Rio de Janeiro, Brazil. The sensitivity of antibody ELISAs 21 
depends on the duration and severity of herd infection. (Silvia, 2001).  22 
2.9.1  The principle of the indirect ELISA (iELISA): 23 
The indirect enzyme-linked immunosorbent assay (iELISA) is a semi-quantitative 24 
serological test that measures antibodies in serum samples. Plates are first coated with 25 
the specific antigen. Serum samples are added, if the serum has antibodies, it will bind 26 
to the antigen in the wells. An anti-species conjugate is added and attaches to bound 27 
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antibodies. It causes the substrate to change colour. The colour development is 1 
proportional to the concentration of antibodies for the tested antigen. 2 
 3 
Figure 2.3  Representation of an indirect ELISA; vlab.amrita.edu, (2011). Retrieved 1 July 2016, from 4 
vlab.amrita.edu 5 
 6 
 7 
 8 
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3 Chapter 3 
Materials and Methods 
3.1 Sampling and handling of samples 
Blood was collected in heparinized tubes from free-ranging and captive lions. From 
each lion, 10 ml of blood was collected and stimulated with mycobacterial antigens and 
mitogens.  
 The majority of samples were collected from the KNP in Mpumalanga (n=17); all 
samples were opportunistically collected during routine immobilisation of lions. Animal 
ethics clearance was obtained from UNISA (2014/CAES/187) and the University of 
Pretoria (Section 20 approval was obtained from the Department of Agriculture (DAFF) 
(12/11/1/1/18) 
Samples were kept at ambient temperature, and packaged using the 3 layer packaging 
system; samples were collected in Vacutainer tubes, placed in plastic bag and put in a 
Styrofoam box with a tightly secured lid and transported to the laboratory where they 
were processed within 8 hours from collection.  
3.2 Evaluation of mitogens as positive cell control. 
Preparation of the mitogens 
Pokeweed (PWM): 5% in NaCl solution was made up and 5 ml of 0.9% NaCl to PWM 
10mg to make up a final concentration of 2 mg/ml (stock solution and store at -20 ºC. 
Phorbol 12- Myristate 13- Acetate (PMA): An aqueous solution of PMA (1 mg) powder 
was made by using a concentrated solution of 100 % DMSO (1 ml) and then diluted in a 
small aliquot with water to a final concentration of 1mg/ml. 
Calcium Ionophore (CAI): 1ml of DMSO (100%, Sigma) was added to 1mg of 
Ionomycin (lyophilized powder) to a final concentration of 1mg/ml. 
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3.2.1 Whole blood processing 
1.5 ml heparinised blood (mixed thoroughly by inverting four times) was dispensed into 
2 ml tubes (Eppendorf) and stimulated using one of the following conditions: PMA/CaI at 
different concentrations (100 ng/ml/2 μg/ml & 50 ng/ml/1 μg/ml) (Sigma, South Africa), 
(PWM 10 μg/ml, Sigma, South Africa) , av PPD (20 μg/ml) 1 and bov PPD (20 μg/ml) 
(Ondersterpoort Biological products) and incubated at 37 C in 5% CO₂ for 24 and 48 
hours respectively. The negative control consisted of blood stimulated with RPMI 
medium and the positive control consisted of blood stimulated with a mitogen. Plasma 
was harvested after incubation, and stored at -80 ºC until further use in the lion-specific 
IFN- capture ELISA. 
3.3 Optimisation of the IFN- ELISA 
The lion-specific IFN- ELISA developed my Maas et al. (2012) was re-evaluated and 
further optimized to harmonize the procedure with a similar rhino-specific interferon- 
ELISA developed by Morar et al. (2007). Harmonization was done in order to ensure 
that the assay test results of the lion specific IFN-  ELISA are equivalent to what has 
previously described on the rhino-specific interferon- ELISA as it has already been 
optimized. 
3.3.1 Optimization of the IFN- monoclonal capture antibody 
The first step was to evaluate 2 different concentrations for coating of the IFN- capture 
monoclonal antibody (mAb) (LI2B7.2G7) (Maas et al, 2012) using (Greiner Bio 
One Microlon , extra high binding,  655061,  E120700P) plates  . Wells were coated with 
50 µl volumes using either 2 µg/ml or 4 µg/ml mAb diluted in phosphate buffered saline 
(PBS; ph 7.2). Plates were incubated for one hour on an orbital shaker (250 rpm) at 37 
C. Coating buffer was discarded and 200 µl of PBS with 1% bovine serum albumin 
(BSA; Sigma, South Africa) (blocking buffer) was added. Plates were incubated as 
above and the blocking buffer was discarded, washing was optional after blocking. 
Recombinant lion IFN- (rLIFN-) produced by U-Protein Express BV, Utrecht The 
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Netherlands (Maas et al., 2010) was titrated in duplicate over 7 wells in a 2-fold dilution 
series (3 500- 54 pg/ml), 50 l/well in blocking buffer, from row A to row G, and row H 
received only diluent as negative control. Plates were incubated as above and washed 
three times with wash buffer (PBS with 0.1% Tween-20 (Sigma). Biotinylated detecting 
antibody mAb (Li7A9B4) (Maas et al, 2012) (50 μl/well) was added at 1:5 000 dilution in 
blocking buffer. Plates were incubated for 30 minutes at 37 C on a shaker. After 
incubation plates were washed as described above and 50 l/well of 1:5 000 
streptavidin conjugated to horseradish peroxidase (strep-avidin-HRP 80; Stereospecific 
Detection Technologies, Germany) in blocking buffer was added. Plates were incubated 
for 15 minutes on a shaker at 37 C and then washed six times before 50 μl/well ready-
made TMB substrate (Sigma,  T4444)  ) was added, colour reaction was stopped after 
20 minutes by adding 50 μl/well 2 M H₂So₄. Plates were read at a wave length of 450 
nm with a reference read at 650 nm. 
3.3.2 Optimization of the IFN- monoclonal detection antibody and conjugate 
The second step was to evaluate different concentrations of biotinylated IFN- detection 
mAb (Li7A9B4) (Maas et al, 2012) and strep-avidin-HRP 80. Plates were coated with 2 
g/ml of IFN- capture mAb and rLIFN- was titrated as described previously in 
3.1.1.The detection antibody and streptavidin-HRP 80 was diluted in the blocking buffer 
and added in 50 l volumes to respective wells as indicated in Table 3.1  
 Column 
1 
Column 
2 
Column 
3 
Column 
4 
Column 
5 
Column 
6 
Dilution for 
IFN- detection 
mAb (Li7A9B4) 
1:5 000 1:10 000 1:5 000 1:10 000 1:5 000 1:10 000 
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Table 3.1 Different concentrations of biotinylated detecting mAb and strep-avidin- horse radish 
peroxidase conjugate were tested in the following combinations. 
 
The assay was then performed as previously described in  
 
3.3.3 Optimization of the blocking buffer 
The initial assay was developed using 1.3% Universal Casein Diluent (Stereospecific 
Detection Technologies, Germany) in PBS as a diluent and blocking agent. The third 
step was to evaluate two different blocking agents: casein and BSA to harmonize with 
the rhino IGRA protocol (Morar et al., 2007). 
ELISA plates were coated with 2g/ml of IFN- capture mAb and rLIFN- was titrated as 
described previously in 3.1.1. RLIFN- was titrated in a two-fold dilution series in all 
columns (1 to 12) of the plate starting at a concentration of 3500 pg/ml in row A and 
ending at a concentration of 54 pg/ml in row G. Row H received only diluent as 
negative. The assay was performed as previously described in 3.3.1 but PBS with 1% 
BSA was used for blocking and as diluent on the first half of the plate (columns 1 to 6) 
and PBS with 1.3% casein (universal casein diluent SDT, Germany) was used for 
blocking and diluent on the other half of the plate (columns 7 to 12).  
3.3.4 Lion IFN- capture ELISA optimized protocol 
A final protocol was optimized. Extra high binding ELISA plates (655061, E120700P 
Greiner Bio-One Microlon) were coated with 50 μl/well of capture mAa (LI2B7.2G7) 
diluted in PBS to a concentration of 2µg/ml. The plate was incubated for an hour at 250 
Dilution for 
strep-avidin 
HRPO-
conjugate 
1:2 500 1:2 500 1:5 000 1:5 000 1:10 000 1:10 000 
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rpm. After incubation, coating buffer was discarded, and 200 μl of the diluent (PBS 1% 
BSA) was added to each well, the plate was incubated for another hour at 37 °C. After 
blocking, the buffer was discarded, and the plate was washed three times using wash 
buffer (PBS 0.1% Tween-20). Fifty μl/well of supernatant/plasma was added in duplicate 
to appropriate wells according to plate layout, leaving two columns empty for the 
standard curve. For the standard curve, rIFN- was used at a starting concentration of 3 
500 pg/ml followed by a two-fold dilution series to 54 pg/ml. The last well served as the 
blank containing only diluent. The plate was incubated for an hour at ambient 
temperature. Washing was done as described above. Biotinylated detecting mAb 
(Li7A9B4) was added to the diluent at a concentration of 1:5 000 (50 μl/ well) and 
incubated for 30 minutes on a shaker at ambient temperature. After the wash step, 
streptavidin-HRPO80 (Sigma) was added (1:5 000 dilution) and a 15 minutes incubation 
at 37 C followed. Substrate TMB (Sigma) reagent (50 μl/well) was added, the colour 
reaction was stopped after 10 to 20 minutes depending on how fast the reaction was by 
adding 50 μl per well of a 2 molar H₂So₄ solution and plates were read at an optical 
density at 450 nm with a reference read at 650 nm. 
3.4 Data Analysis 
Samples were analysed in duplicate and results were expressed as the averaged 
OD₄₅₀.The statistical comparison used to compare different incubation time and mitogen 
was performed using the ANOVA and Student t-test in Microsoft excel. 
3.4.1 Precision (reproducibility) 
Precision is defined as the quality of being thorough or accurate and reproducibility is 
the measurement of an experiment if whether it can be reproduced as a whole. In this 
regard, the assay was tested to present its reproducibility and its accuracy. 
Four ELISA plates tested on different days were used to determine the precision of the 
assay. This was done by calculating the mean, standard deviation (SD) and coefficient 
of variation (CV). 
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3.4.2 Results calculation 
The lower limit of detection of the assay was calculated based on the OD₄₅₀ reading 
higher than the average OD₄₅₀ of the negative control plus three times the standard 
deviation. Stimulated whole blood supernatants were assayed in duplicate and 4-
parameter logistic curve fitting using rLIFN- was used to calculate concentration levels 
(pg/ml) of FN- detected. 
Whole blood cultures from animals originating from BTB free areas were tested for 
measuring FN-  production. The FN- response of each individual to the two different 
stimulation antigens is listed under the results Table 4.2. 
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4 Chapter 4 
Results 
4.1 Optimization of the IFN- monoclonal capture antibody 
The titration curves for rLIFN- using two different coating concentrations for the capture 
mAb are presented in fig 4.1. The limit of detection was calculated as 3 times the optical 
density (OD) of the negative. The detection limit for coating the plates with 4 and 2 
g/ml of mAb was 219 and 109 pg/ml respectively. Using the mAb at 2 g/ml resulted in 
more colour development and it was best to use as it saves reagents. 
 
Figure 4.1 The titration curves of two different concentrations of IFN- capture mAb are shown. Plates 
were coated with 4 g/ml or 2 g/ml. Each of the lines represent a serial 2-fold titration of rLIFN- ranging 
from 3 500 pg/ml to 55 pg/ml. The lower detecting limit of the assay was determined by calculating the 
negative value three times the average OD value and it was found at 109 pg/ml rLIFN-. 
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4.2  Optimization of the IFN- monoclonal detection antibody and conjugate 
The analytical sensitivity of different concentrations of biotinylated detecting mAb and 
streptavidin conjugated to horse radish peroxidase were tested. The results are shown 
in the table below; the table also represents detection limits obtained from comparing 
the two blocking buffers Figure 4. shows two titration curves for rLIFN- using different 
blocking agents. When PBS with 1% BSA as blocking agent was used, the assay 
developed higher overall OD values when compared to PBS with 1.3% casein as 
blocking agent. The assay with the BSA as blocking agent was more sensitive detecting 
up to109 pg/ml while the assay with casein as blocking agent detected 219 pg/ml of the 
rLIFN-.  
Table 4.1 Detection limits for rIFN- at different concentrations of biotinylated detecting mAb and strep-
avidin-horse radish peroxidase conjugate are shown below. Two different blocking agents were also 
tested. These constituted 1% BSA in PBS and 1.3% Casein in PBS. Columns showing the other results 
not shown on below graph fig 4.2. 
 
 Col 1 Col 2 Col 3 Col 4 Col 5 Col 6 
Dilution for IFN- detection mAb 
(Li7A9B4) 
1:5 
000 
1:10 
000 
1:5 
000 
1:10 
000 
1:5 000 1:10 
000 
Dilution for strep-avidin HRPO-
80 
1:2 
500 
1:2 500 1:5 
000 
1:5 000 1:10000 1:10 
000 
rLIFN- detection with 1% BSA 
blocking 
219 
pg 
219 pg 109 
pg 
219 pg 109 pg 438 pg 
rIFN- detection with 1.3% 
casein blocking 
440 
pg 
220 pg 220 
pg 
220 pg 440 pg 220 pg 
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Figure 4.2 Titration curves of 2 different blocking buffers are shown. Plates were blocked with 1% BSA or 
1.3% casein. Each of the lines represent a serial 2-fold titration of rLIFN- ranging from 3 500 pg/ml to 55 
pg/ml 
4.3 Whole blood stimulation with mitogen for 24 h and 48 h  
Two incubation times were evaluated on five lion blood samples; blood was incubated 
for 24h and 48h respectively before harvesting supernatants. All five of the lion samples 
stimulated with PMA/CaI, produced strong IFN- signals following the 24h and 48h 
incubation. Table 4.1 presents the comparison between PMA and PWM. PMA gives a 
significantly stronger reaction (p <0.05). No significant difference of FN-  (ng/ml) 
production was found after antigen stimulation with bovine and avian PPD. 
 
 
Table 4.1 Concentration values obtained from OD₄₅₀ readings. Whole blood stimulation was 24h and 48h 
assayed in duplicates respectively. Samples were stimulated with PMA/CaI with concentrations of 100 
ng/ml and 2µg/ml and PWM. IFN- responses to PWM and PMA had a significant difference with a 
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(p<0.0002) at 24 and at 48h (p< 0.0198) ANOVA. The mean OD₄₅₀ value of the samples stimulated with 
PMA/Ionomycin differed significantly. 
  24 hrs   48 hrs  
Lion  Neg  PMA PWM Neg  PMA PWM 
N3 22.72 3675 1100.597 102.03 2790.87 633.25 
N5 0.00 3675 831.82 0.00 2790.88 633.25 
Maisha 
32.53 3675 132.6245 50.343 3675 149.02 
Lion 4 
104.79 3675 971.37 140.77 3675 732.59 
Lion 5 
8.836 3675 165.4185 2.93 3675 137.52 
Mean 
33.78 3675.00 640.37 59.80 3321.35 457.13 
Standard 
deviation 41.62 0.00 458.64 61.72 484.26 289.39 
p (24h vs 48h) 
 
0.102 
 
0.2411  
 
0.4867 
 
0.102 
 
0.2411  0 0.4867 
p (PMA vs PWM) 
 0.0002 0.0002  0.0198 
0.0198 
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Figure 4.1  IFN- response in whole blood obtained from 5 lions in response with PMA 24 and 48h 
respectively. The concentration value of the samples stimulated with PMA/ionomycin were highly 
produced in the incubation interval 24 h. P=0.0002 
 
Figure 4.2  IFN- response in whole blood obtained from 5 lions in response with PWM 24h and 48h 
respectively. Both graphs show IFN- responses to PWM had a significant difference (p<0.0002) after 24h 
to 48h compared to the levels observed with PMA/CaI after 24h to 48h respectively. P=0.0198 
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4.4 Precision 
The range and detection limit of the lion IFN- ELISA was determined by testing 
replicates of rILFN- concentrations (0- 3 500 pg/ml). A precision profile was 
constructed by plotting the %CV against the analyte concentration. The working range 
of the assay can be defined as the range where imprecision is below a preset level such 
as 15% as shown on the graph below. 
 
Figure 4.6 The precision profile of the rLIFN- an assay showing nonuniform error. The %CV is plotted 
against the analyte concentration. The working range of the assay can be defined as the range where 
imprecision is below a preset level such as 15%, as shown by the red line. 
4.5 Detection of IFN-y responses 
To determine the effectiveness of whole blood culture for detection of IFN-, blood 
samples from 5 lions were tested. The values from the negative control (medium only) 
were subtracted from the antigen stimulated values to obtain a corrected value. IFN- 
response of each individual are listed in Table 4.2. The mean concentrations of IFN- of 
blood from individual lions stimulated with bv PPD and av PPD for 24h and 48h were 
18.75; 17.69 and 13.39 and 13.03 respectively.  
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Table 4.2 Corrected concentration values of whole blood samples of 5 lions from BTB free areas that 
were stimulated with bovine PPD avian PPD and PMA/CaI. 
  24 hrs   48 hrs  
Lion  PMA/CaI Bv ppd Av ppd PMA/CaI Bv ppd Av ppd 
N3 3652.28 62.45 64.91 2768.15 4.79 36.81 
N5 3675 0 0 2790.88 19.04 22.41 
Maisha 3642.47 11.89 3.89 3642.47 13.02 6.53 
Lion 4 3570.21 28.29 28.53 3570.21 27.87 -4.62 
Lion 5 3666.164 -8.836 -8.836 3666.164 2.26 4.05 
Mean 3641.22 18.75 17.69 3287.5748 13.39 13.03 
Standard 
deviation 
41.62 28.10 29.80 465.20 10.48 16.49 
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5 Chapter 5 
Discussion, conclusion and recommendation 
 
5.1 Discussion 
The complex nature of diagnosis of tuberculosis has resulted in limited diagnostic tests 
available for wildlife. Studies previously done in lions have used intradermal tuberculin 
test or antibody detection (Keet D. F et al 2010). The intradermal tuberculin tests have 
proved to be impractical for use in lions because it is time consuming based on two 
sedations within a three-day interval (72h), they cause stress for the animal, and 
recapturing after 3 days is not guaranteed.  
The aim of this study was to optimise an IGRA for detection of tuberculosis in free 
ranging and captive lions. 
For optimisation, specific conditions linked to the performance of the assay were 
determined and evaluated. The conditions included the optimal concentrations of 
capture and detecting antibody, optimal concentrations of the conjugate and optimal 
concentrations of the blocking buffer. The detection limit of rLIFN- was determined and 
it was used as a standard curve on each plate to normalise the data. Selection of 
suitable mitogens for use as an indicator of cell viability and determination of optimum 
incubation times for cell stimulation was performed.  
The optimal concentration of the capture antibody was 2 µg/ml. When 4 µg/ml was used 
it resulted in overall lower OD values. The use of 2 µg/ml will result in a significant 
saving of reagent.   
The detecting antibody and conjugate could be used at 1:5000 or 1:10000 dilutions and 
could detect rLFN- at109 pg/ml. The detection limit obtained from the current study is in 
agreement with the 160 pg/ml that was previously described by Maas et al. 
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(2012).Though there was no significant difference when using 1:5000 and 1:10000 
combinations of detecting and conjugate, it was decided to use the 1:5000 combination 
of both detecting and conjugate in further ELISAs. The use of 1% BSA in PBS yielded 
results with less background and provided an increased signal of the lower detection 
limit of the assay.  
PMA/CaI and PWM were used as cell stimulators for the effectiveness of IFN- 
production in whole blood cultures. The best performing mitogen was based on the 
strongest OD response and the most consistent when repeating testing using the same 
sample, PMA/CaI was recognized as the best performing mitogen for use as a positive 
control in stimulation of whole blood cultures. Whole blood samples stimulated with 
PMA/CaI and PWM from five lions were tested and IFN- production was found to be 
produced in similar quantities for both 24h and 48h when stimulated with PMA/CaI as 
shown in Figure 4.1. The results also show that responses to PMA/CaI were greater 
than those of PWM in all 5 lions, this supports the use of PMA/CaI as a viability control 
as what was used by Rhodes et al., 2008 in his feline assay and Maas et al., 2012 in 
the development of this assay.  
The assay test performance was assessed by analysing the repeatability of the assay. 
This was done by determining the precision profile which was used to determine the 
valid performance range of the assay. This was done in accordance to the guidelines 
described by (Crowther, J. R. 2001). The working range of the assay can be defined as 
the range where imprecision is below a preset level such as 15%, as shown in Figure 
4.5. When the cut-off for the standard curve is determined as 2 standard deviations 
above the mean of the negative control, the assay has a limit of detection of 55 pg/ml, 
however there is very little variation between OD values towards the end of the titration 
curve (as the line flattens out) and therefore little significant difference between 
consecutive concentration values. Therefore, we opted to select the cut-off as 3 times 
the mean of the negative control which gives a cut-off of 109pg/ml. This decision is 
supported when evaluating the precision profile in figure 4.5 when the %CV of each 
dilution of the positive control obtained over several runs and on different days, is 
plotted against the concentration range; a profile of the precision of the assay is 
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obtained. According to this profile the assay performs well in the range of 3500 to 109 
pg/ml with %CV below 15%.  
The results obtained in this study demonstrate the ability of the assay to detect IFN- 
responses when stimulated with mitogen. Whole blood culture samples that were 
stimulated with PMA/CaI produced higher responses of IFN-. Samples stimulated with 
both bovine ppd and avian ppd at 48h produced as much IFN- responses as compared 
to responses observed at 24h as shown in Table 4.2. Nonetheless, none of the animals 
reacted well to the mycobacterial antigens as compared to the reactions produced by 
the mitogen. More samples of infected and un-exposed lions are needed to determine 
cut-off values for the assay. 
The ELISA described by Maas was adapted and re-evaluated, in this study. The original 
ELISA was developed in line with the Rhino protocol (D. Morar., 2007) and used 1.3% 
universal casein diluent at 75 µl/well as a blocking buffer, which means only a quarter of 
the well was blocked. In this revised protocol PBS 1% BSA was used as a blocking 
buffer at 200 ul/well, this means that the whole well was blocked and less non-specific 
binding occurred.  
In the original protocol supernatants of stimulated blood were diluted 1:1 in 1.3% casein 
buffer with bovine serum, with bovine serum added to a final concentration of 10%. In 
the revised protocol supernatants were only diluted in 1% BSA in PBS and no bovine 
serum was added. 
The incubation stage of the revised protocol is half of what was initially described (1h), 
the same incubation time after addition of the supernatants was used in the rhino 
protocol. Combination of detecting antibody and streptavidin- HRP80 dilutions were 
evaluated done by comparing 1:10000 diluted in 0.43% casein at a concentration of 
10% and 1:20000 (initial protocol) and at 1:5000 and 1:10000 for the current study.  
Results show that the 1:5000 and the 1:10000 combinations were similar, though there 
was no significant difference between the two. We chose to use the 1:5000 dilutions for 
both detecting antibody and conjugate.  
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Washing was done six times in the reviewed protocol as opposed to eight times in the 
initial protocol. Colour reactions were only read after 20 minutes incubation. The final 
optimal conditions are thoroughly described in chapter 3 (3.1.1). 
On the initial protocol, the coating step was followed by the washing step, which we 
opted to skip when optimizing the assay; this was decided based on ways to shorten the 
assay as the step did not make a difference if it was done after the coating step or the 
blocking step. 
5.2 Conclusion and recommendation 
In conclusion, the aim of the study was to optimise the lion specific IGRA specific to 
lions and the work done on the current study contributes to the optimisation of the IGRA 
for detecting tuberculosis in lions. The assay can detect IFN- from supernatants 
harvested from whole blood cultures stimulated with specific antigens and mitogens. 
Though, the main challenge is obtaining the fresh samples from lions with known 
tuberculosis status. Recommendation for future work is further validation of the assay 
for diagnostic testing in wildlife is still required.  
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